Fatal Cytomegalovirus Pneumonia and Associated Herpes Virus Infection in a Relapsed/Refractory Multiple Myeloma Patient Treated with Bortezomib plus Dexamethasone

Publisher： Karger

E-ISSN： 1662-6575|2|2|140-143

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.2, Iss.2, 2009-07, pp. : 140-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytomegalovirus reactivation accompanied by varicella zoster virus reactivation or reinfection in an adult patient of multiple myeloma during bortezomib therapy

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 1, 2018-01 ,pp. : 108-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors associated with second‐line triplet therapy in routine care in relapsed/refractory multiple myeloma

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 45-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM‐003 trial for pomalidomide plus low‐dose dexamethasone

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 6, 2015-03 ,pp. : 820-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Very Low Doses of Thalidomide as Single Agent in Relapsed/Refractory Multiple Myeloma

By  

Acta Haematologica, Vol. 116, Iss. 1, 2006-07 ,pp. : 70-71

Karger

Access to resources Recommend Favorite

Efficacy of VDT PACE‐like regimens in treatment of relapsed/refractory multiple myeloma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 179-186

John Wiley & Sons Inc

Access to resources Recommend Favorite